Pharmesis International Ltd

BFK

Company Profile

  • Business description

    Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its operating segments are Western drugs/TCH Procurement, which are chemically formulated drugs and are marketed under the Kinna brand; TCM-formulated drugs/IP rental, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution, which derives maximum revenue, refers to agency products and internally manufactured products which are marketed through the distribution arm. The company derives revenue from the sale of medicines to domestic customers in China.

  • Contact

    5 Kallang Sector
    No. 03-02
    Singapore349279
    SGP

    T: +65 68460766

    https://www.pharmesis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

Stocks News & Analysis

stocks

CBA earnings: Business lending powers on, but costs and credit bear watching

Our view after the bank reports first quarter earnings.
stocks

Apple earnings review: Revenue beats estimates as memory crunch threatens margins

Apple shares are trading at record highs after posting solid results.
stocks

Nvidia: Cutting our fair value estimate by 19% given the firm’s CEO transition and turmoil

We’re reducing our long-term revenue estimates.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,204.5069.70-0.75%
CAC 408,368.917.550.09%
DAX 4026,749.9521.93-0.08%
Dow JONES (US)52,347.5550.460.10%
FTSE 10010,902.5639.470.36%
HKSE23,637.60370.95-1.55%
NASDAQ25,136.27229.82-0.91%
Nikkei 22561,142.35322.990.53%
NZX 50 Index14,173.6885.55-0.60%
S&P 5007,561.6730.73-0.40%
S&P/ASX 2009,082.2064.60-0.71%
SSE Composite Index3,634.3521.48-0.59%

Market Movers